Target intelligence / Profile preview

Dental enamel (main biological tissue) and Hydroxyapatite (main mineral component) (Enamel (no universal abbreviation; Hydroxyapatite often abbreviated as HAp or HA))

Target
Enamel (no universal abbreviation; Hydroxyapatite often abbreviated as HAp or HA)
Molecular classification
Other
01

Overview

Dental enamel is the outermost, highly mineralized layer of teeth, consisting predominantly (95-98%) of hydroxyapatite crystals arranged in rods that provide exceptional hardness and resistance to mechanical wear[3][5][6]. Hydroxyapatite, with the formula Ca₁₀(PO₄)₆(OH)₂, is the principal mineral phase making up enamel, dentin, and bone, conferring both structural rigidity and chemical stability[1][4]. The organization and interaction of hydroxyapatite nanocrystals within the enamel matrix give teeth their durable barrier function yet make them vulnerable to demineralization by acids, underlying the pathogenesis of dental caries and erosion[3][6]. While not themselves molecular drug targets, enamel and hydroxyapatite surfaces are the focus of therapeutic interventions aimed at remineralization and protection, such as fluoride and bioactive mineral compounds[1][4].

Other names
EnamelHApHAHydroxylapatiteApatite
02

Mechanism of action

Fluoride ions replace hydroxyl groups in hydroxyapatite, forming fluorapatite which resists acid dissolution. Remineralization of enamel by deposition of calcium and phosphate, restoring lost mineral content. Nano-hydroxyapatite particles fill enamel defects and promote repair/regrowth of surface mineral.

03

Biological functions

Protection of teeth from physical and chemical damageProvides hardness and wear resistance for masticationStructural mineralization of teeth and bonesActs as a barrier to bacterial invasion and acids
04

Disease associations

Dental caries (demineralization of enamel)Tooth erosion and sensitivityDevelopmental enamel defects (amelogenesis imperfecta)Other (structural basis for disease, not as a molecular target)
05

Safety considerations

Potential for overexposure to fluoride causing dental fluorosisLimitations in biomaterial use (mechanical brittleness for artificial hydroxyapatite implants)
06

Interacting drugs

Fluoride

2 more in the full profile.

07

Biomarkers

None

Beyond the preview

Go deeper on Dental enamel (main biological tissue) and Hydroxyapatite (main mineral component) (Enamel (no universal abbreviation; Hydroxyapatite often abbreviated as HAp or HA)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dental enamel (main biological tissue) and Hydroxyapatite (main mineral component) (Enamel (no universal abbreviation; Hydroxyapatite often abbreviated as HAp or HA)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call